Biodexa Pharmaceuticals Plc (BDRX)
1.24
-0.08
(-6.06%)
USD |
NASDAQ |
May 02, 11:38
Biodexa Pharmaceuticals Total Assets (Quarterly): 13.43M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 13.43M |
| June 30, 2023 | 10.04M |
| June 30, 2023 | 10.04M |
| December 31, 2022 | 6.686M |
| June 30, 2022 | 11.74M |
| June 30, 2022 | 11.74M |
| December 31, 2021 | 17.43M |
| June 30, 2021 | 11.45M |
| June 30, 2021 | 11.45M |
| December 31, 2020 | 13.38M |
| June 30, 2020 | 14.77M |
| June 30, 2020 | 14.77M |
| December 31, 2019 | 40.51M |
| June 30, 2019 | 36.16M |
| Date | Value |
|---|---|
| June 30, 2019 | 36.16M |
| December 31, 2018 | 25.94M |
| June 30, 2018 | 46.87M |
| June 30, 2018 | 46.87M |
| December 31, 2017 | 66.52M |
| June 30, 2017 | 58.91M |
| June 30, 2017 | 58.91M |
| December 31, 2016 | 69.64M |
| June 30, 2016 | 76.20M |
| June 30, 2016 | 76.20M |
| December 31, 2015 | 94.88M |
| June 30, 2015 | 66.47M |
| June 30, 2015 | 66.47M |
| December 31, 2014 | 72.63M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
6.686M
Minimum
Dec 2022
40.51M
Maximum
Dec 2019
17.32M
Average
13.38M
Median
Dec 2020
Total Assets (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 282.62M |
| NuCana PLC | 35.43M |
| Autolus Therapeutics PLC | 375.38M |
| Mereo BioPharma Group PLC | 66.50M |
| Bicycle Therapeutics PLC | 595.34M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.470M |
| Shareholders Equity (Quarterly) | 5.959M |
| Current Ratio | 1.262 |